오라제닉스(OGEN)는 NYSE MKT에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.53 (+0.53%), 시가총액 $0.00B, 52주 범위 $0.12 ~ $4.93.
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
오라제닉스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
오라제닉스의 현재 주가는 $0.53 (+0.53%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
오라제닉스의 시가총액은 약 $0.00B입니다.
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. I